Biocytogen Pharmaceuticals Beijing Co Ltd (2315)

Currency in HKD
24.60
-0.66(-2.61%)
Closed·

2315 Financial Summary

Key Ratios

P/E Ratio154.73
Price/Book6.24
Debt / Equity68%
Return on Equity4.12%
Dividend Yield0.00%
EBITDA289.05M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
0.21 / --
Revenue / Forecast
569.96M / 570.54M
EPS Revisions
Last 90 days

FAQ

What were Biocytogen Pharmaceuticals Beijing's earnings for the latest quarter?

The Biocytogen Pharmaceuticals Beijing EPS (TTM) is 0.08. Biocytogen Pharmaceuticals Beijing reported sales of 569.96, net income of 84.22, and EPS of 0.21 for the latest quarter.

What was Biocytogen Pharmaceuticals Beijing's net income for the latest quarter?

Biocytogen Pharmaceuticals Beijing's net income for the latest quarter was 84.22.

How did Biocytogen Pharmaceuticals Beijing's performance compare year-over-year in the latest quarter?

The company's revenue moved from 410.50 in the previous quarter to 569.96 in the latest quarter, and net income moved from -50.67 to 84.22 compared to the previous quarter.

What is Biocytogen Pharmaceuticals Beijing's net profit margin on a TTM basis?

Biocytogen Pharmaceuticals Beijing's trailing twelve months (TTM) net profit margin is 3.42%.

How does Biocytogen Pharmaceuticals Beijing's debt to equity ratio compare to industry standards?

Biocytogen Pharmaceuticals Beijing's total debt-to-equity ratio is 68.00%.

What is Biocytogen Pharmaceuticals Beijing's return on investment on a TTM basis?

Biocytogen Pharmaceuticals Beijing's trailing twelve months (TTM) return on investment (ROI) is 4.12%.

Did Biocytogen Pharmaceuticals Beijing gain or lose cash last quarter?

In the latest quarter, Biocytogen Pharmaceuticals Beijing's net change in cash was -1.39 million.

What were Biocytogen Pharmaceuticals Beijing's total assets and liabilities in the latest quarter?

As of the latest quarter, Biocytogen Pharmaceuticals Beijing reported total assets of 2,415.31 million and total liabilities of 534.91 million.

How has Biocytogen Pharmaceuticals Beijing's total revenue grown this year?

Biocytogen Pharmaceuticals Beijing's total revenue was 410.50 in the previous quarter and 569.96 in the latest quarter.

What is Biocytogen Pharmaceuticals Beijing's gross margin on a TTM basis?

Biocytogen Pharmaceuticals Beijing's trailing twelve months (TTM) gross margin is 79.12%.

What was Biocytogen Pharmaceuticals Beijing's revenue per share for the latest quarter?

Biocytogen Pharmaceuticals Beijing's revenue per share for the latest quarter was 3.76.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.